4,8-dichloro-[1,2,3,4]tetrazolo[1,5-a]quinoxaline | 900306-03-8

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 二氮杂萘
• 英文名称: 4,8-dichloro-[1,2,3,4]tetrazolo[1,5-a]quinoxaline
• 英文别名: 4,8-dichlorotetrazolo[1,5-a]quinoxaline
• CAS: 900306-03-8
• 化学式: C₈H₃Cl₂N₅
• 分子量: 240.051
• InChiKey: OYQUYHKZXOMPKE-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.3
• 重原子数：
  15
• 可旋转键数：
  0
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  56
• 氢给体数：
  0
• 氢受体数：
  4

反应信息

• 作为产物：
  描述：

  2,6-dichloro-3-hydrazinoquinoxaline 在 盐酸 、 sodium nitrite 作用下， 以 水 为溶剂， 以95%的产率得到4,8-dichloro-[1,2,3,4]tetrazolo[1,5-a]quinoxaline
  参考文献：
  名称：

  HETEROCYCLIC INHIBITORS OF HISTAMINE RECEPTORS FOR THE TREATMENT OF DISEASE

  摘要：

  本发明涉及化合物和方法，这些化合物和方法可能用作H1R和/或H4R的抑制剂，用于治疗或预防炎症性、自身免疫性、过敏性和眼部疾病。

  公开号：

  US20100120741A1

文献信息

• HETEROCYCLIC INHIBITORS OF HISTAMINE RECEPTORS FOR THE TREATMENT OF DISEASE
  申请人：Borchardt Allen J.

  公开号：US20100120741A1

  公开（公告）日：2010-05-13

  The present invention relates to compounds and methods which may be useful as inhibitors of H 1 R and/or H 4 R for the treatment or prevention of inflammatory, autoimmune, allergic, and ocular diseases.

  本发明涉及化合物和方法，这些化合物和方法可能用作H1R和/或H4R的抑制剂，用于治疗或预防炎症性、自身免疫性、过敏性和眼部疾病。
• INHIBITORS OF CRL4 UBIQUITIN LIGASE AND USES THEREOF
  申请人：Cornell University

  公开号：US20150196546A1

  公开（公告）日：2015-07-16

  The invention is directed to a method of treating a cancer in an animal and a method of increasing DNA repair activity in an animal. The methods comprise administering to an animal in need thereof an effective amount of a small molecule substance that interferes with the activity of CUL4A, such as a 1,3-benzoxathiol-2-one compound, a pyridine thione compound, a 2,6-diamino-4-thiopyran-3,5-dicarbonitrile compound, or a 1,2,4-triazole-3-thiol compound.

  本发明涉及一种治疗动物癌症和增加动物DNA修复活性的方法。该方法包括向需要治疗的动物中投与有效量的干扰CUL4A活性的小分子物质，比如1,3-苯并噻吩-2-酮化合物、吡啶硫酮化合物、2,6-二氨基-4-硫代吡喃-3,5-二氰基化合物或1,2,4-三唑-3-硫醇化合物。
• Inhibitors of CRL4 ubiquitin ligase and uses thereof
  申请人：Cornell University

  公开号：US10617683B2

  公开（公告）日：2020-04-14

  The invention is directed to a method of treating a cancer in an animal and a method of increasing DNA repair activity in an animal. The methods comprise administering to an animal in need thereof an effective amount of a small molecule substance that interferes with the activity of CUL4A, such as a 1,3-benzoxathiol-2-one compound, a pyridine thione compound, a 2,6-diamino-4-thiopyran-3,5-dicarbonitrile compound, or a 1,2,4-triazole-3-thiol compound.

  本发明涉及一种治疗动物癌症的方法和一种提高动物 DNA 修复活性的方法。这些方法包括向有需要的动物施用有效量的干扰CUL4A活性的小分子物质，如1,3-苯并氧硫醇-2-酮化合物、吡啶硫酮化合物、2,6-二氨基-4-噻喃-3,5-二甲腈化合物或1,2,4-三唑-3-硫醇化合物。
• [EN] HETEROCYCLIC INHIBITORS OF HISTAMINE RECEPTORS FOR THE TREATMENT OF DISEASE<br/>[FR] INHIBITEURS HÉTÉROCYLIQUES DES RÉCEPTEURS DE L'HISTAMINE DESTINÉS AU TRAITEMENT D'UNE MALADIE
  申请人：KALYPSYS INC

  公开号：WO2010030785A2

  公开（公告）日：2010-03-18

  The present invention relates to compounds and methods which may be useful as inhibitors of H1R and/or H4R for the treatment or prevention of inflammatory, autoimmune, allergic, and ocular diseases.
• [EN] INHIBITORS OF CRL4 UBIQUITIN LIGASE AND USES THEREOF<br/>[FR] INHIBITEURS DE L'UBIQUITINE-LIGASE CRL4 ET SES UTILISATIONS
  申请人：UNIV CORNELL

  公开号：WO2014031759A2

  公开（公告）日：2014-02-27

  The invention is directed to a method of treating a cancer in an animal and a method of increasing DNA repair activity in an animal. The methods comprise administering to an animal in need thereof an effective amount of a small molecule substance that interferes with the activity of CUL4A, such as a 1,3-benzoxathiol-2-one compound, a pyridine thione compound, a 2,6-diamino-4-thiopyran-3,5-dicarbonitrile compound, or a 1,2,4-triazole-3-thiol compound.